Table 1.
|
Animal model
|
Transplanted cells
|
Density of transplanted cells
|
Transplantation site
|
Therapeutic effects
|
Unique features
|
Results
|
Ref.
|
1 | Mice (Transgenic 3 x Tg- AD and Thy1-APP) | NSCs | 100000 cells in 2 µL | Hippocampus | Aβ-clearance, increased synaptic density | Neprilysin gene transfer | Not assessed | Blurton-Jones et al[37] |
2 | Mouse (NBM lesion) | ESC-derived neurosphere | 400 µL/injection, 1-5 × 104 cells/µL | Prefrontal and parietal cortices | ChAT and serotonin-positive neurons | ChAT + cells↑ | Working memory ↑ | Wang et al[27] |
3 | Rat (Forebrain), Okadaic acid | NSC (rat) | 5 µL /injection site (2 injections) 2 × 104 cells/mL | Hippocampus and cerebral cortex | replace damaged or lost neuron | NGF(human), gene transfer | Memory ↑ | Wu et al[28] |
4 | Mice (Transgenic Tg2576) | MSCs from human UCB | 100000 cells/ Mouse (i.v.) | Systematic | Anti-inflammatory, anti-amyloidogenic | None | Not assessed | Nikolic et al[29] |
5 | Rat (NBM lesion) Ibotenic acid | ESC-derived NPC (mouse) | 2 × 105 cells in 2 µL | Forebrain specially NBM | Forming cholinergic cell phenotype | Shh-primed | Water maze↑; Spatial probe↑ | Moghadam et al[30] |
6 | Mouse (3X TG-AD) | NSC (mouse) | 100000 murine NSCs | Hippocampus | Neurotropic effects | BDNF-mediated effect | Working memory↑ | Blurton-Jones et al[31] |
7 | Rat (Hippocampus) Kainic acid | Immortalized NSC (human, HB1.F3) | 1 × 106 cells/rat | Hippocampal CA3 region | Migrate to injured site differentiate into neurons overexpressing ChAT | ChAT (human), gene transfer | Water maze↑; Spatial probe↑ | Park et al., 2012a[33] |
8 | Rat (NBM lesion) AF64A toxin | Immortalized NSC (human, HB1.F3) | 1 × 106 cells/rat | ICV | migrate to various brain regions including cerebral cortex and hippocampus | ChAT (human) gene transfer | Water maze↑; Spatial probe↑ | Park et al[32] |
9 | Mice (Transgenic APP/PS1) | MSCs from human UCB | 1 × 105 cells in 3 µL(3 injection once after 2 wk) | Hippocampus | Anti-inflammatory, anti-amyloidogenic, anti-phosphorylation of tau | None | Improved learning and memory | Lee et al[34] |
10 | Mouse (Hippocampus) Ibotenic acid | Immortalized NSC (human, HB1.F3) | 2 × 105 cell suspension 2 µL | Hippocampus | migrated to lesion sites and differentiated into neurons and astrocytes | NGF (human); Gene transfer | Water maze↑; Spatial probe↑ | Lee et al[35] |
11 | Mice (Transgenic APP/PS1) | MSCs from human UCB | 2 × 104 cells per head | Hippocampus, cortical region | Anti-inflammatory, Aβ-clearance | - | Not assessed | Kim et al[36] |
NBM: Nucleus basalis of Meynert; ESC: Embryonic stem cell; NGF: Nerve growth factor; 3XTG: Triple transgenic/APP-presenilin-tau; BDNF: Brain-derived growth factor; ChAT: Choline acetyltransferase; NPC: Neural precursor cell; NSC: Neural stem cell; SHH: Sonic hedgehog protein; UCB: Umbilical cord blood; Aβ: Beta-amyloid; MSCs: Mesenchymal stem cells; APP: Amyloid-β precursor protein; ICV: Intra-cerebro ventricular.